The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication

被引:11
|
作者
Van Cor-Hosmer, Sarah K. [1 ]
Daddacha, Waaqo [1 ]
Kelly, Z. [1 ]
Tsurumi, Amy [1 ]
Kennedy, Edward M. [1 ]
Kim, Baek [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14648 USA
关键词
HIV-1; Reverse transcriptase; dNTP binding affinity; Cellular dNTP pools; Steady and presteady kinetics; MURINE LEUKEMIA-VIRUS; DNA-SYNTHESIS; AMINO-ACID; DRUG-RESISTANCE; STERIC GATE; CELL-CYCLE; HIV-1; FIDELITY; LAMIVUDINE; MACROPHAGE;
D O I
10.1016/j.virol.2011.11.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) has a unique tight binding to dNTP substrates. Structural modeling of Ala-114 of HIV-1 RT suggests that longer side chains at this residue can reduce the space normally occupied by the sugar moiety of an incoming dNTP. Indeed, mutations at Ala-114 decrease the ability of RT to synthesize DNA at low dNTP concentrations and reduce the dNTP-binding affinity (K-d) of RT. However, the K-d values of WT and A114C RT remained equivalent with an acyclic dNTP substrate. Finally, mutant A114 RT HIV-1 vectors displayed a greatly reduced transduction in nondividing human lung fibroblasts (HLFs), while WT HIV-1 vector efficiently transduced both dividing and nondividing HLFs.Together these data support that the A114 residue of HIV-1 RT plays a key mechanistic role in the dNTP binding of HIV-1 RT and the unique viral infectivity of target cell types with low dNTP pools. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 50 条
  • [31] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Sri Nurjannah
    Francisca Srioetami Jayanti
    Ummu Syauqah Tanoerahardjo
    Caecilia Hapsari Ceriapuri Al Musyahadah
    Muhammad Nasrum Sukowati
    Current HIV/AIDS Reports, 2024, 21 : 31 - 39
  • [32] UNEQUAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ERROR RATES WITH RNA AND DNA TEMPLATES
    BOYER, JC
    BEBENEK, K
    KUNKEL, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 6919 - 6923
  • [33] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Nurjannah
    Jayanti, Sri
    Tanoerahardjo, Francisca Srioetami
    Al Musyahadah, Ummu Syauqah
    Sukowati, Caecilia Hapsari Ceriapuri
    Massi, Muhammad Nasrum
    CURRENT HIV/AIDS REPORTS, 2024, 21 (02) : 31 - 39
  • [34] ISOLATION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS RESISTANT TO THE NON-NUCLEOTIDE REVERSE-TRANSCRIPTASE INHIBITOR MKC-442
    SEKI, M
    SADAKATA, Y
    YUASA, S
    BABA, M
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1995, 6 (02) : 73 - 79
  • [35] HIGHLY SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHICH ARE PARTICULARLY TARGETED AT THE REVERSE-TRANSCRIPTASE
    DECLERCQ, E
    SNOECK, R
    PATHOLOGIE BIOLOGIE, 1993, 41 (03): : 230 - 236
  • [36] Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
    Gupta, Soumi
    Fransen, Signe
    Paxinos, Ellen E.
    Stawiski, Eric
    Huang, Wei
    Petropoulos, Christos J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 1973 - 1980
  • [37] Rational Approaches for the Design of Effective Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitors
    Ribone, Sergio R.
    Quevedo, Mario A.
    Madrid, Marcela
    Brinon, Margarita C.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (01) : 130 - 138
  • [38] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236
  • [39] Topoisomerase I dissociates human immunodeficiency virus type 1 reverse transcriptase from genomic RNAs
    Takahashi, H
    Sawa, H
    Hasegawa, H
    Nagashima, K
    Sata, T
    Kurata, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (04) : 1073 - 1078
  • [40] Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins
    Ng, TB
    Lam, TL
    Au, TK
    Ye, XY
    Wan, CC
    LIFE SCIENCES, 2001, 69 (19) : 2217 - 2223